Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Review of medication error sources associated with inpatient subcutaneous insulin: recommendations for safe and cost-effective dispensing practices.

McKay C, Schenkat D, Murphy K, et al. Review of medication error sources associated with inpatient subcutaneous insulin: recommendations for safe and cost-effective dispensing practices. Hosp Pharm. 2022;57(6):689-696. doi:10.1177/00185787221095771.

Save
Print
August 24, 2022
McKay C, Schenkat D, Murphy K, et al. Hosp Pharm. 2022;57(6):689-696.
View more articles from the same authors.

Insulin is a high-alert medication due to heightened risk for serious patient harm if administered incorrectly. This review presents types of common errors (e.g., wrong patient, cross-contamination), pros and cons of potential dispensing strategies, and the impact of organizational factors (e.g., workflows, cost) on safe dispensing. Additionally, the authors make recommendations for dispensing, taking organization factors into account.

Save
Print
Cite
Citation

McKay C, Schenkat D, Murphy K, et al. Review of medication error sources associated with inpatient subcutaneous insulin: recommendations for safe and cost-effective dispensing practices. Hosp Pharm. 2022;57(6):689-696. doi:10.1177/00185787221095771.